Showing results (61-70 of 75) with videos related to
Sort By:
Pageof 8
Journal of Medicinal Chemistry|July 23, 1993
Novel 2-substituted tetrahydro-3H-benz[e]indolamines: highly potent and selective agonists acting at the 5-HT1A receptor as possible anxiolytics and antidepressantsA G Romero, J A Leiby, R B McCall, et al.Journal of Veterinary Pharmacology and Therapeutics|May 13, 2008
Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (Cerenia) for the prevention of emesis and motion sickness in catsM A Hickman, S R Cox, S Mahabir, et al.The American Journal of Physiology|January 1, 1996
Role of serotonergic neurons in the maintenance of the 10-Hz rhythm in sympathetic nerve dischargeH S Orer, M E Clement, S M Barman, et al.Journal of Medicinal Chemistry|January 1, 1981
Tetrahydro-2-benzoxepins: a novel family of hypotensivesR E TenBrink, J M McCall, D T Pals, et al.Child Development|April 1, 1987
Roundtable: what is temperament? Four approachesH H Goldsmith, A H Buss, R Plomin, et al.Journal of Medicinal Chemistry|August 7, 1992
Novel indolodioxanes with antihypertensive effects: potent ligands for the 5-HT1A receptorM D Ennis, M E Baze, M W Smith, et al.Journal of Medicinal Chemistry|January 1, 1982
1-(alkylamino)isochromans: hypotensives with peripheral and central activitiesJ M McCall, R B McCall, R E TenBrink, et al.Journal of Medicinal Chemistry|March 19, 1993
Centrally acting serotonergic agents. Synthesis and structure-activity relationships of C-1- or C-3-substituted derivatives of 8-hydroxy-2-(di-n-propylamino)tetralinC H Lin, S R Haadsma-Svensson, R A Lahti, et al.Journal of Medicinal Chemistry|April 16, 1993
Centrally acting serotonergic and dopaminergic agents. 1. Synthesis and structure-activity relationships of 2,3,3a,4,5,9b-hexahydro-1H-benz[e]indole derivativesC H Lin, S R Haadsma-Svensson, R A Lahti, et al.Cephalalgia : an International Journal of Headache|December 18, 2002
Preclinical studies characterizing the anti-migraine and cardiovascular effects of the selective 5-HT1D receptor agonist PNU-142633R B McCall, R Huff, C L Chio, et al.Pageof 8